Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T9DN
|
|||
| Former ID |
DIB010539
|
|||
| Drug Name |
Dimiracetam
|
|||
| Synonyms |
BND-11624; Dimiracetam, Neurotune; NT-11624; NMDA receptor antagonist (oral, neuropathic pain/osteoarthritic pain), Neurotune
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neuropathic pain [ICD-11: 8E43.0] | Phase 2 | [1] | |
| Company |
Brane Discovery Srl
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H8N2O2
|
|||
| Canonical SMILES |
C1CC(=O)N2C1NC(=O)C2
|
|||
| InChI |
1S/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)
|
|||
| InChIKey |
XTXXOHPHLNROBN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 126100-97-8
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01135251) Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy. U.S. National Institutes of Health. | |||
| REF 2 | Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain. Neuropharmacology. 2014 Jun;81:85-94. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.